Key facts
- It has raised $2.8M; the latest was Seed Round ($2.8M) in Oct 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Yuanmei Microbiology
- ·The full record, as it builds
Funding rounds
No funding rounds for Yuanmei Microbiology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yuanmei Microbiology
Developer of a microbial non-drug therapy system intended to advance health treatments through biological regulation. The company offers nationally endorsed live biological preparations with zero hormone and antibiotic detection, enabling individuals with eye, skin, pain, and nasal conditions to experience enhanced safety and therapeutic efficacy.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Yuanmei Microbiology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yuanmei Microbiology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yuanmei Microbiology in its N-PORT filings yet. We sweep new filings monthly.